CH646961A5 - Derivate oder isoxazolin-5-essigsaeure, verfahren zu deren herstellung und diese enthaltende mikrobizide zusammensetzungen. - Google Patents

Derivate oder isoxazolin-5-essigsaeure, verfahren zu deren herstellung und diese enthaltende mikrobizide zusammensetzungen. Download PDF

Info

Publication number
CH646961A5
CH646961A5 CH452779A CH452779A CH646961A5 CH 646961 A5 CH646961 A5 CH 646961A5 CH 452779 A CH452779 A CH 452779A CH 452779 A CH452779 A CH 452779A CH 646961 A5 CH646961 A5 CH 646961A5
Authority
CH
Switzerland
Prior art keywords
formula
carbon atoms
group
alkyl group
compound
Prior art date
Application number
CH452779A
Other languages
German (de)
English (en)
Inventor
Robert Charles Kelly
Wendell Wierenga
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CH646961A5 publication Critical patent/CH646961A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/04—Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH452779A 1978-05-15 1979-05-15 Derivate oder isoxazolin-5-essigsaeure, verfahren zu deren herstellung und diese enthaltende mikrobizide zusammensetzungen. CH646961A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90596378A 1978-05-15 1978-05-15

Publications (1)

Publication Number Publication Date
CH646961A5 true CH646961A5 (de) 1984-12-28

Family

ID=25421749

Family Applications (1)

Application Number Title Priority Date Filing Date
CH452779A CH646961A5 (de) 1978-05-15 1979-05-15 Derivate oder isoxazolin-5-essigsaeure, verfahren zu deren herstellung und diese enthaltende mikrobizide zusammensetzungen.

Country Status (10)

Country Link
JP (1) JPS54148781A (fr)
AU (1) AU526380B2 (fr)
BE (1) BE876261A (fr)
CH (1) CH646961A5 (fr)
DE (1) DE2918878A1 (fr)
FR (1) FR2426049A1 (fr)
GB (1) GB2023135B (fr)
IT (1) IT1116816B (fr)
NL (1) NL7903771A (fr)
SE (2) SE448376B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4643807A (en) * 1985-12-13 1987-02-17 The Dow Chemical Company Process for electrochemically forming an aromatic compound containing one or more alpha-acyloxylated aliphatic substitutent(s)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856807A (en) * 1972-03-13 1974-12-24 Upjohn Co L-({60 s,5s)-{60 -amino-3-chloro-2-isoxazoline-5-acetic acid
US3878047A (en) * 1973-02-02 1975-04-15 Upjohn Co Process for production of AT-125
US3944562A (en) * 1974-04-17 1976-03-16 The Upjohn Company αS, 4S, 5R α-Amino-3-chloro-4-hydroxy-2-isoxazoline-5-acetic acid

Also Published As

Publication number Publication date
SE7904163L (sv) 1979-11-16
BE876261A (fr) 1979-11-16
IT1116816B (it) 1986-02-10
GB2023135A (en) 1979-12-28
FR2426049B1 (fr) 1983-06-17
SE8501965D0 (sv) 1985-04-23
SE8501965L (sv) 1985-04-23
DE2918878A1 (de) 1979-11-22
IT7949040A0 (it) 1979-05-14
GB2023135B (en) 1982-08-25
AU526380B2 (en) 1983-01-06
NL7903771A (nl) 1979-11-19
FR2426049A1 (fr) 1979-12-14
JPS54148781A (en) 1979-11-21
SE448376B (sv) 1987-02-16
AU4672379A (en) 1979-11-22

Similar Documents

Publication Publication Date Title
EP0491226B1 (fr) Acide pyridyl dihydroxy hepténoique substitué et ses sels
DE3688827T2 (de) Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
EP0111873B1 (fr) Dérivés de l'acide cis, endo-aza-2 bicyclo(5.3.0)décane-carboxylique-3, procédé pour leur préparation, compositions les contenant et leur application
DE69107250T2 (de) Neue 4-Aminobuttersäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneizubereitungen.
DE69711411T2 (de) Verwendung von gamma-hydroxybuttersäureamiden in der behandlung von drogenabhängigkeit und insbesondere von alcoholismus
DE2705025A1 (de) Xanthinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2812625A1 (de) Oximderivate der 3-acetoxymethyl-7- aminothiazolyl-acetamido-cephalosporansaeure, ihre herstellung und pharmazeutische mittel
EP0451790A1 (fr) 2-isoxazolines et isoxazoles 3,5-disubstitués, procédé pour leur préparation,médicaments les contenant et leur utilisation
DE69229339T2 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
CH630604A5 (de) Verfahren zur herstellung von neuen acetylenderivaten von aminosaeuren.
DE2851028A1 (de) Neue indolo eckige klammer auf 2.3-a eckige klammer zu chinolizidine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitung
DE69116237T2 (de) Derivate von Hexahydroazepine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE1795022C3 (de) Lysergsäurederivate
DE60131416T2 (de) Chirale fluochinolon-argininsalzformen
DE68905171T2 (de) Benzol-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die diese enthalten.
EP0534904A1 (fr) Imidazolylméthylpyridines
EP0349609A1 (fr) Esters d'acides amines, leur procede de production et leur utilisation
DE69208464T2 (de) N-((4,5-dihydroxy- und 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracen-yl)carbonyl)aminosäure zur therapie osteoartikulärer leiden
DE1620326A1 (de) Verfahren zur Herstellung von Aziridinderivaten
CH646961A5 (de) Derivate oder isoxazolin-5-essigsaeure, verfahren zu deren herstellung und diese enthaltende mikrobizide zusammensetzungen.
DE69615845T2 (de) Polycyclische alkaloid-derivate als nmda-rezeptor-antagonisten
DE2625110A1 (de) Cyclopropanolderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2751571A1 (de) Stereoisomere von 1-(1'-benzyl-2'- pyrryl)-2-di-sek.-butylaminoaethanol, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE69522810T2 (de) Streptograminderivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen
DE69210214T2 (de) 2-(2,3-dicarboxycyclopropyl)-glycin und ein verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased